Canada markets open in 7 hours 10 minutes

Fennec Pharmaceuticals Inc. (FRX.TO)

Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
12.50-0.08 (-0.64%)
At close: 11:13AM EDT
Currency in CAD

Valuation Measures4

Market Cap (intraday) 338.75M
Enterprise Value 362.96M
Trailing P/E N/A
Forward P/E 29.41
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)11.43
Price/Book (mrq)84.57
Enterprise Value/Revenue 17.08
Enterprise Value/EBITDA -29.36

Trading Information

Stock Price History

Beta (5Y Monthly) 0.40
52-Week Change 319.47%
S&P500 52-Week Change 324.49%
52 Week High 315.43
52 Week Low 39.27
50-Day Moving Average 313.50
200-Day Moving Average 312.13

Share Statistics

Avg Vol (3 month) 3276
Avg Vol (10 day) 3140
Shares Outstanding 527.1M
Implied Shares Outstanding 627.27M
Float 815.38M
% Held by Insiders 114.60%
% Held by Institutions 155.83%
Shares Short (Apr 30, 2024) 474.84k
Short Ratio (Apr 30, 2024) 4400.19
Short % of Float (Apr 30, 2024) 40.39%
Short % of Shares Outstanding (Apr 30, 2024) 40.28%
Shares Short (prior month Mar 28, 2024) 475.66k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:3
Last Split Date 3Sept 05, 2014

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -75.50%
Operating Margin (ttm)-18.67%

Management Effectiveness

Return on Assets (ttm)-29.67%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)21.25M
Revenue Per Share (ttm)0.80
Quarterly Revenue Growth (yoy)534.20%
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-16.05M
Diluted EPS (ttm)-0.82
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)13.27M
Total Cash Per Share (mrq)0.49
Total Debt (mrq)30.95M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)3.56
Book Value Per Share (mrq)-0.43

Cash Flow Statement

Operating Cash Flow (ttm)-17.14M
Levered Free Cash Flow (ttm)-12.35M